Evidence map›Paper›PMID 41420085›Full record

ArticleScientific reports2025

DFT investigation of boron- and zinc-doped C24 fullerenes as efficient nanosensors for molly detection.

Mohammed Ghazwani, Umme Hani

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mohammed GhazwaniDepartment of Pharmaceutics, College of Pharmacy, King Khalid University, 62223, Al Faraa, Abha, Saudi Arabia. my.ghazwani@kku.edu.sa.
Umme HaniDepartment of Pharmaceutics, College of Pharmacy, King Khalid University, 62223, Al Faraa, Abha, Saudi Arabia.

Funding

King Khalid University RGP2/514/46
6 · The paper itself

Abstract

Reliable detection of 3,4-methylenedioxymethamphetamine (Molly) remains a major analytical challenge due to its widespread recreational use and high risk of combination with toxic substances, as well as the limitations of conventional laboratory methods such as GC-MS and Raman spectroscopy. This study employs Density Functional Theory (DFT), Time-Dependent DFT (TD-DFT), Quantum Theory of Atoms in Molecules (QTAIM), Natural Bond Orbital (NBO), and Non-Covalent Interaction (NCI) analyses to design and evaluate pristine and doped C24 fullerenes (BC23 and ZnC23) as potential colorimetric and electrochemical nanosensors for Molly detection. Computational findings reveal that boron and zinc doping enhance structural stability, with cohesive energies increasing from 149 kcal mol− 1 (C24) to 194 kcal mol− 1 (BC23) and 188 kcal mol− 1 (ZnC23). Electronic analysis shows that doping reduces the HOMO-LUMO gap from 6.12 eV (C24) to 5.68 eV (BC23) and 5.24 eV (ZnC23), improving reactivity and charge transfer. The BC23@Molly complex (Conformer 4) exhibited the highest adsorption energy (− 18.19 kcal mol− 1) and a remarkable redshift in λmax from 444 to 660 nm, confirming its superior colorimetric sensitivity. Conversely, the ZnC23@Molly complex (Conformer 6) demonstrated the fastest recovery time (3.8 × 10− 4 s) and highest electrical conductivity (2.78 × 109 A m− 2), identifying it as the most efficient electrochemical sensor. QTAIM and NCI analyses confirmed the presence of medium-strength hydrogen bonding and dispersive interactions, while NBO data revealed strong π→π (21.13 kcal mol− 1)* and LP→π (55.97 kcal mol− 1)* transitions in BC23@Molly. Collectively, these results establish BC23 as the most effective colorimetric sensor and ZnC23 as the optimal electrochemical sensor for rapid, sensitive, and field-deployable Molly detection.

Indexed as

Colorimetric sensingDFTDoped fullerenes C24Electrochemical sensorMDMA detectionMolly

Identifiers

PMID41420085
PMCPMC12824287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.